Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC vs PRP for Knee Osteoarthritis
NCT03271229Phase 2Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Sep 2019
- Primary completion
- Jan 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of autologous bone marrow cell concentrate in osteoarthritis (OA) (2 arms), sponsored by Mayo Clinic. Primary endpoints: Occurrence of Adverse Events at 12 months and Morbidity at 12 months. Planned start Sep 2019; status: withdrawn.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03271229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03271229.